Study investigates time perception in Alzheimer’s disease and its preclinical stage, subjective cognitive decline (SCD), revealing specific alterations in temporal processing that could be early markers of cognitive decline.
Biotech in Israel: Holding on to business as usual amid uncertain times
In the middle of our Zoom interview, Mati Gill, Tel Aviv-based CEO of venture studio AION Labs, excused himself calmly to find shelter when a